PFBT
IRMD icon

Parkside Financial Bank & Trust’s iRadimed IRMD Stock Holding History

Parkside Financial Bank & Trust’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2K Hold
190
– – ﹤0.01% 1418
2026
Q1 		$18.3K Hold
190
– – ﹤0.01% 1338
2025
Q4 		$18.5K Hold
190
– – ﹤0.01% 1329
2025
Q3 		$13.5K Hold
190
– – ﹤0.01% 1398
2025
Q2 		$11.4K Buy
+190
New +$10.4K ﹤0.01% 1445

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Parkside Financial Bank & Trust's IRMD Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its iRadimed (IRMD) position steady in Q2 2026 at 190 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1418.

Parkside Financial Bank & Trust first reported a position in IRMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $18.5K in Q4 2025. 213 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Parkside Financial Bank & Trust held 190 shares of iRadimed worth $18.2K as of Q2 2026.
  • Parkside Financial Bank & Trust left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1418 holding.
  • Parkside Financial Bank & Trust first reported a position in iRadimed in Q2 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's iRadimed position peaked at $18.5K in Q4 2025.
  • 213 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.